Cbeyond, Inc. (CBEY) Misses Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts CBEY Hot Sheet
Price: $9.99 --0%
Financial Fact:
Operating (loss) income: -9.05M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Operating (loss) income: -9.05M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Cbeyond, Inc. (NASDAQ: CBEY) reported Q3 EPS of ($0.04), $0.02 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $121.5 million versus the consensus estimate of $121.78 million.
For earnings history and earnings-related data on Cbeyond, Inc. (CBEY) click here.
For earnings history and earnings-related data on Cbeyond, Inc. (CBEY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Ascendis Pharma (ASND) Tops Q2 EPS by 132c
- Legence Corp. (LGN) Misses Q2 EPS by 58c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
